Browse by author
Lookup NU author(s): Dr Calum Hamilton, Dr Paul DonaghyORCiD, Dr Michael FirbankORCiD, Nicola Barnett, Dr Louise Allan, Dr George Petrides, Professor John-Paul TaylorORCiD, Professor John O'Brien, Professor Alan ThomasORCiD
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
The aim of this study was to determine whether there was a significant change in cardiac [123I]-metaiodobenzylguanidine uptake between baseline and follow-up in individuals with mild cognitive impairment with Lewy bodies (MCI-LB) who had normal baseline scans. Eight participants with a diagnosis of probable MCI-LB and a normal baseline scan consented to a follow-up scan between 2 and 4 years after baseline. All eight repeat scans remained normal; however, in three cases uptake decreased by more than 10%. The mean change in uptake between baseline and repeat was −5.2% (range: −23.8% to +7.0%). The interpolated mean annual change in uptake was −1.6%.
Author(s): Greenfinch G, Hamilton CA, Donaghy PC, Firbank M, Barnett NA, Allan L, Petrides GS, Taylor JP, O'Brien JT, Thomas AJ
Publication type: Article
Publication status: Published
Journal: BJPsych Open
Year: 2024
Volume: 10
Issue: 6
Online publication date: 05/12/2024
Acceptance date: 05/06/2024
Date deposited: 03/02/2025
ISSN (electronic): 2056-4724
Publisher: Cambridge University Press
URL: https://doi.org/10.1192/bjo.2024.766
DOI: 10.1192/bjo.2024.766
Data Access Statement: The data and materials that support the findings of this study are available from the corresponding author, G.G., upon reasonable request.
Altmetrics provided by Altmetric